data in the original s.c./i.v
Based on Obesity Canada guidelines and clinical trials (typically over ~1 year): Saxenda: ~58% total body weight loss Wegovy: ~1015% total body weight loss Tirzepatide: ~1520% (or more) total body weight loss weight loss is gradual and occurs over several months, with the most significant changes seen after reaching the full therapeutic dose results vary depending on adherence, lifestyle factors, and individual response 7
It digests easily and rarely triggers the nausea or bloating that fattier proteins can cause
The PCOS Connection For people with PCOS, weight loss can restore more regular cycles, reduce insulin resistance, and increase the likelihood of ovulating consistentlymaking both natural conception and fertility treatments more effective
"People with heart disease or high heart disease risk are more likely to remain alive, keep their kidney function, and stay off dialysis if they are treated with semaglutide." So, how does a drug developed to help people with type 2 diabetes and popularised as a weight-loss therapy help slow the progression of kidney disease